secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0000914475-23-000049
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine CMO Eiry Roberts to retire in 2025; search underway
--------------------------------------------------------------

- Chief Medical Officer Eiry W. Roberts, M.D., notified Neurocrine of her plan to retire in 2025 for personal reasons.
- Dr. Roberts will remain as CMO until her replacement is on-boarded; the company has initiated a search.
- Her retirement is not due to any disagreement with Neurocrine's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/0000914475-23-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/nbix-20230710.htm
  HTML page:      https://secwatch.observer/filing/0000914475-23-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer